Takahiro Yamauchi

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

|Feb 16, 2023
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Naoko Hosono, SungGi Chi, Takahiro Yamauchi

|Nov 17, 2022
Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment.

Takayuki Ikezoe, Kensuke Usuki, Kensuke Aida

|Aug 01, 2022
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).

Dai Maruyama, Shinsuke Iida, Ryunosuke Machida

|Jun 30, 2018
An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.

Jun-Ichiro Kida, Takayuki Tsujioka, Shin-Ichiro Suemori

Pageof 1

Frequent Collaborators

3 joint publications

Junya Kuroda

2 joint publications

Makoto Yoshimitsu

2 joint publications

Kensuke Usuki

2 joint publications

Suguru Fukuhara